Functional IOL Implantation in Patients With Epiretinal Membrane
Recruiting
N/A
Interventional Study
Cataract
Intraocular Lens Complication
Epiretinal Membrane
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 90 (estimated)
- Sponsor
- Eye & ENT Hospital of Fudan University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
We have designed this prospective study to evaluate macular involvement and epiretinal membrane (ERM) grading by OCT in eyes with ERM and to compare clinical outcomes after implantation of Enhance IOL with standard monofocal IOL in eyes with ERM grading preoperatively, aiming to find out whether functional IOL is benefit for patients with ERM.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Requirement for cataract extraction
* Age \> 40 years
* Axial length in 21mm to 25mm
* ERM
Exclusion Criteria:
* Residual corneal astigmatism \> 1.0 D
* Amblyopia
* Previous ocular surgery
* Other ocular pathologies apart from mERM, such as diabetic retinopathy, macular dege…
Contacts